Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Y / Y Equity Change	61.96 %	17.49 %	14.51 %	-14.49 %	-2.88 %
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	6.05 %	-	-	-	-

APLS all Ratios >> Back to APLS Management Effectiveness >> See Quarterly APLS Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Dec 31 2025) ROE improved to 6.05 % compare to previous year, due to net income growth.

Financial Statements
Apellis Pharmaceuticals Inc 's Equity	$ 370 Millions	Annual APLS's Balance sheet
Apellis Pharmaceuticals Inc 's Annual Income	$ 22 Millions	Annual APLS's Income Statement
Where are APLS's Income coming from?		Visit APLS's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.